Artificial intelligence (AI), designed to simulate human intelligence in machines, is increasingly applied in medicine, particularly radiology and obstetrics[1].
In OBGYN, AI can analyze imaging data to automatically identify and classify structures such as the placenta or fetal organs with high accuracy.
By automating image acquisition, performing biometric measurements, and assisting in the detection of structural anomalies – including congenital heart disease – AI has the potential to enhance routine fetal ultrasound. However, optimal integration into clinical workflows remains uncertain, and potential risks must be considered.
Day 3 of Obstetrics Days will explore the opportunities, challenges, and practical applications of AI in obstetric screening.
November 6 | 7pm (CET)
Ultrasound
November 6, 7 pm (CET) / 1 pm (EST)
Join Prof. Reza Razavi,Dr. Jacqueline Matthew, and Dr. Thomas Day as they share their insights on the potential uses of AI in fetal ultrasound, examine the risks and possible harms, and discuss how unmet clinical needs can guide the responsible adoption of AI in healthcare.
Register now for this last session of the Obstetrics Days, and participate in the live Q&A to share your perspective on this evolving field.
Program
Prof. Reza Razavi, MD, PhDReza Razavi, MD, PhD, is Professor of Pediatric Cardiovascular Science at King’s College London (KCL) and a Paediatric Cardiologist at Evelina London Children’s Hospital, part of Guy’s and St Thomas’ NHS Foundation Trust (GSTT).
His research focuses on imaging, artificial intelligence (AI), and biomedical engineering related to cardiovascular disease.
He has previously served as Vice President (Research) at KCL, Non-Executive Director of GSTT, and Director of both the London AI Centre for Value-Based Healthcare and KCL’s Centre for Medical Engineering.
In addition to his academic and clinical roles, he leads Fraiya, a KCL/GSTT spin-out company that has developed AI technology to transform pregnancy ultrasound.
References
Disclaimers